A prospective, randomized, double-blinded, split-face pilot study comparing Q-switched 1064-nm Nd:YAG versus 532-nm Nd:YAG laser for the treatment of solar lentigines

J Cosmet Laser Ther. 2018 Nov-Dec;20(7-8):395-397. doi: 10.1080/14764172.2018.1439968. Epub 2018 Feb 26.

Abstract

Treating photoaging with laser technologies has increased in popularity due to their efficacy, minimal downtime, and side effects. New Q-Switched (QS) Nd:YAG lasers' frequency doubled with 532 nm wavelength can both target epidermal chromophores as well as stimulate collagen production. The objective of this study was to compare single-pulsed 1064-nm Nd:YAG with dual-pulsed 532-nm/1064-nm QS laser for reducing solar lentigines. Ten subjects with solar lentigines were enrolled in this prospective, randomized, double-blind, split-face study. Subjects received six laser treatments (half-face dual, half single) at 2-week intervals. Blinded investigator and subject assessments were conducted 1 month posttreatment to evaluate global skin improvement, safety, and patient satisfaction. Blinded investigator assessments showed statistically significant improvement in the dual-treated side. Patient satisfaction was also statistically significantly increased in the dual-treated side. In conclusion, dual laser treatment can result in superior and safe global improvement of photoaging.

Keywords: Photoaging; Q-switched laser; skin quality.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Cosmetic Techniques
  • Double-Blind Method
  • Female
  • Humans
  • Lasers, Solid-State
  • Lentigo / radiotherapy*
  • Low-Level Light Therapy / adverse effects
  • Low-Level Light Therapy / methods*
  • Middle Aged
  • Patient Satisfaction
  • Pilot Projects
  • Prospective Studies
  • Skin Aging / radiation effects*